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provides a summary overview of the seven GWAS. We identified a total of 865 lead 92 SNPs across the seven GWAS. The lead SNPs are located in 611 approximately independent 93 loci, where a locus is defined as the set of all SNPs in weak LD (pairwise r 2 > 0.1) with a lead 94 SNP. The SNP heritabilities of the seven phenotypes range from ~0.05 (for general risk 95 tolerance) to ~0.16 (for the first PC of the four risky behaviors). 96 97 Genetic overlap 98 There is substantial overlap across the results of our GWAS. For example, 72 of the 124 general-99 risk-tolerance lead SNPs are in loci that also contain lead SNPs for at least one of the other 100 GWAS, including 45 for adventurousness and 49 for at least one of the four risky behaviors or 101 their first PC. To empirically assess if this overlap could be attributed to chance, we conducted a 102 resampling exercise under the null hypothesis that the lead SNPs of our supplementary GWAS 103 are distributed independently of the 124 general-risk-tolerance lead loci. We strongly rejected 104 this null hypothesis (P < 0.0001; Supplementary Information section 3.3.3) . 105 Several regions of the genome stand out for being associated both with general risk tolerance and 106 with all or most of the supplementary phenotypes. We tested whether the signs of the lead SNPs 107 located in these regions tend to be concordant across our primary and supplementary GWAS. We strongly rejected the null hypothesis of no concordance (P < 3×10 -30 ; Supplementary Information section 3.2.3), suggesting that these regions represent shared genetic influences, 110 rather than colocalization of causal SNPs. Fig. 1b and Extended Data Fig. 3.4 show local 111 Manhattan plots for some of these regions. The long-range LD region 12 on chromosome 3 (~83.4 112 to 86.9 Mb) contains lead SNPs from all seven GWAS as well as the most significant lead SNP 113 from the general risk tolerance GWAS, rs993137 (P = 2.14×10 -40 ), which is located in the gene 114 CADM2. Another long-range LD region, on chromosome 6 (~25.3 to 33.4 Mb), covers the HLA-115 complex and contains lead SNPs from all GWAS except drinks per week. Three candidate 116 inversions (i.e., genomic regions that are highly prone to inversion polymorphisms; 117 Supplementary Information section 2.9.2) on chromosomes 7 (~124.6 to 132.7 Mb), 8 (~7.89 118 to 11.8 Mb), and 18 (~49.1 to 55.5 Mb) contain lead SNPs from six, five, and all seven of our 119 GWAS, respectively. Finally, four other LD blocks 13 that do not overlap known long-range LD 120 or candidate inversion regions each contain lead SNPs from five of our GWAS (including 121 general risk tolerance). The two long-range LD regions and the three candidate inversions have 122 previously been found to be associated with numerous phenotypes, including many cognitive and 123 neuropsychiatric phenotypes 14 . 124 To investigate genetic overlap at the genome-wide level, we estimated genetic correlations with 125 self-reported general risk tolerance using bivariate LD Score regression 9 . (For this and all 126 subsequent analyses involving general risk tolerance, we used the summary statistics from the 127 combined meta-analysis of our discovery and replication GWAS.) The estimated genetic 128 correlations with our six supplementary phenotypes are all positive, larger than ~0.25, and highly 129 significant (P < 2.3×10 -30 ; Fig. 2) , indicating that SNPs associated with higher general risk 130 tolerance also tend to be associated with riskier behavior. The largest estimated genetic adjustment of the phenotypic correlations for measurement error. The comparatively large 139 genetic correlations support the view that a general factor of risk tolerance partly accounts for 140 cross-domain variation in risky behavior 15, 16 and imply that this factor is genetically influenced. 141 The lower phenotypic correlations suggest that environmental factors are more important 142 contributors to domain-specific risky behavior 17,18 . 143 To increase the precision of our estimates of the SNPs' effects on general risk tolerance, we 144 leveraged the high degree of genetic overlap across our phenotypes by conducting Multi-Trait 145 Analysis of GWAS (MTAG) 19 . We used as inputs the summary statistics of our GWAS of 146 general risk tolerance, of our first five supplementary GWAS (i.e., not including the first PC of 147 the four risky behaviors), and of a previously published GWAS on lifetime cannabis use 20 148 (Supplementary Information section 9). MTAG increased the number of general-risk-tolerance 149 lead SNPs from 124 to 312 (Extended Data Fig. 9 .1, Supplementary Table 9 .1). 150 We also estimated genetic correlations between general risk tolerance and 28 additional 151 phenotypes ( Fig. 2 and in Supplementary Table 7 .1). These included phenotypes for which we 152 could obtain summary statistics from previous GWAS, as well as five phenotypes for which we 153 conducted new GWAS. The estimated genetic correlations for the personality traits extraversion 154 ("̂$ = 0.51, SE = 0.03), neuroticism (-0.42, SE = 0.04), and openness to experience (0.33, SE = 155 0.03) are substantially larger in magnitude than previously reported phenotypic correlations 21 , 156 pointing to substantial shared genetic influences among general risk tolerance and these traits. 157 After Bonferroni correction, we also find significant positive genetic correlations with the 158 neuropsychiatric phenotypes ADHD, bipolar disorder, and schizophrenia. Viewed in light of the 159 genetic correlations we find with risky behaviors classified as externalizing (e.g., substance use, 160 elevated sexual behavior, and fast driving), these results suggest the hypothesis that the overlap 161 with the neuropsychiatric phenotypes is driven by their externalizing component. To gain insights into the biological mechanisms through which genetic variation influences 165 general risk tolerance, we conducted a number of analyses. First, we systematically reviewed the 166 literature that aimed to link risk tolerance to biological pathways (Supplementary Information 167 section 11). Our review covered studies based on candidate genes (i.e., specific genetic variants used as proxies for biological pathways), pharmacological manipulations, biochemical assays, 169 genetic manipulations in rodents, as well as other research designs. Our review identified 132 170 articles that matched our search criteria ( Supplementary Table 11 .1). 171 Previous work has focused on five main biological pathways: the steroid hormone cortisol, the 172 monoamines dopamine and serotonin, and the steroid sex hormones estrogen and testosterone. 173 Using a MAGMA 22 competitive gene-set analysis, we found no evidence that SNPs within genes 174 associated with these five pathways tend to be more associated with general risk tolerance than 175 SNPs in other genes ( Supplementary Table 11 .3). Further, none of the other bioinformatics 176 analyses we report below point to these pathways. 177 We also examined the 15 most commonly tested autosomal genes within the dopamine and 178 serotonin pathways, which were the focus of most of the 34 candidate-gene studies identified by 179 our literature review. We verified that the SNPs available in our GWAS results tag most of the 180 genetic variants typically used to test the 15 genes. Across one SNP-based test and two gene-181 based tests, we found no evidence of non-negligible associations between those genes and 182 general risk tolerance ( Fig. 1c and Supplementary Table 11 .4). (We note, however, that some 183 brain regions identified in analyses we report below are areas where dopamine and serotonin 184 play important roles.) 185 Second, we performed a MAGMA 22 gene analysis to test each of ~18,000 protein-coding genes with P values less than 10 -5 in our GWAS of general risk tolerance (Supplementary 193 Information section 12.4). 194 Both the Gene Network and the DEPICT analyses separately point to a role for glutamate and 195 GABA neurotransmitters, which are the main excitatory and inhibitory neurotransmitters in the 196 brain, respectively 25 ( Fig. 3a and Supplementary Tables 12.4 and 12.8). To our knowledge, no 197 published large-scale GWAS of cognition, personality, or neuropsychiatric phenotypes has pointed to clear roles both for glutamate and GABA (although glutamatergic neurotransmission 199 has been implicated in recent GWAS of schizophrenia 26 and major depression 27 ). Our results 200 suggest that the balance between excitatory and inhibitory neurotransmission may contribute to 201 variation in general risk tolerance across individuals. 202 The Gene Network and the DEPICT tissue enrichment analyses also both separately point to 203 enrichment of the prefrontal cortex and the basal ganglia ( Fig. 3b and Supplementary Tables   204 12.4, 12.6, and 12.7). The cortical and subcortical regions highlighted by DEPICT include some 205 of the major components of the cortical-basal ganglia circuit, which is known as the reward 206 system in human and non-human primates and is critically involved in learning, motivation, and 207 decision-making, notably under risk and uncertainty 28, 29 . We caution, however, that our results 208 do not point exclusively to the reward system. 209 Lastly, we used stratified LD Score regression 30 to test for the enrichment of SNPs associated 210 with histone marks in 10 tissue or cell types (Supplementary Information section 12.1) . 211 Central nervous system tissues are the most enriched, accounting for 44% (SE = 3%) of the 212 heritability while comprising only 15% of the SNPs (Extended Data Fig. 12.3a and 213 Supplementary Table 12 .2). Immune/hematopoietic tissues are also significantly enriched. 214 While a role for the immune system in modulating risk tolerance is plausible given prior 215 evidence of its involvement in several neuropsychiatric disorders 26, 27 , future work is needed to 216 confirm this result and to uncover specific pathways that might be involved. 217 218 Polygenic prediction 219 We constructed polygenic scores of general risk tolerance to gauge their potential usefulness in 220 empirical research (Supplementary Information section 10) . We used the Add Health, HRS, 221 NTR, STR, UKB-siblings, and Zurich cohorts as validation cohorts ( Supplementary Table 1 .1 222 provides an overview of these cohorts; the UKB-siblings cohort comprised individuals with at 223 least one full sibling in the UKB). For each validation cohort, we constructed the score using 224 summary statistics from a meta-analysis of our discovery and replication GWAS that excluded 225 the cohort. Our measure of predictive power is the incremental R 2 (or pseudo-R 2 ) from adding 226 the score to a regression of the phenotype on sex, birth year, and the top ten principal 227 components of the genetic relatedness matrix.
Our preferred score was constructed with LDpred 31 . In the UKB-siblings cohort, which is our 229 largest validation cohort (+ ~ 35,000), the score's predictive power is 1.6% for general risk 230 tolerance, 1.0% for the first PC of the four risky behaviors, 0.8% for number of sexual partners, 231 0.6% for automobile speeding propensity, and ~0.15% for drinks per week and ever smoker. 232 Across our validation cohorts, the score is also predictive of several personality phenotypes and a 233 suite of real-world measures of risky behaviors in the health, financial, career, and other domains 234 (Extended Data Figs. 10.1-10.2 and Supplementary Tables 10.1-10.3) . The incremental R 2 we 235 observe for general risk tolerance is consistent with the theoretical prediction, given the SNP 236 heritability of general risk tolerance (Table 1 ) and the imperfect genetic correlations across the 237 GWAS and validation cohorts 32, 33 (Supplementary Information section 10.4) . Our results provide insights into biological mechanisms that influence general risk tolerance. Our 241 bioinformatics analyses point to the role of gene expression in brain regions that have been 242 identified by neuroscientific studies on decision-making, notably the prefrontal cortex, basal 243 ganglia, and midbrain, thereby providing convergent evidence with that from neuroscience 28, 29 . 244 Yet our analyses failed to find evidence for the main biological pathways that had been 245 previously hypothesized to influence risk tolerance. Instead, our analyses implicate genes 246 involved in glutamatergic and GABAergic neurotransmission, which were heretofore not 247 generally believed to play a role in risk tolerance. 248 Although our focus has been on the genetics of general risk tolerance and risky behaviors, 249 environmental and demographic factors account for a substantial share of these phenotypes' 250 variation. We observe sizeable effects of sex and age on general risk tolerance in the UKB data 251 (Extended Data Fig. 1.1) , and life experiences have been shown to affect both measured risk 252 tolerance and risky behaviors (e.g., refs. 34,35) . The data we have generated will allow 253 researchers to construct and use polygenic scores of general risk tolerance to measure how 254 environmental, demographic, and genetic factors interact with one another. 255 For the behavioral sciences, our results bear on the ongoing debate about the extent to which risk 256 tolerance is a "domain-general" as opposed to a "domain-specific" trait. Low phenotypic 257 correlations in risk tolerance across decision-making domains have been interpreted as supporting the domain-specific view 17, 18 . Across the risky behaviors we study, we find that the 259 genetic correlations are considerably higher than the phenotypic correlations (even after the latter 260 are corrected for measurement error) and that many lead SNPs are shared across our phenotypes. 261 These observations suggest that the low phenotypic correlations across domains are due to The table provides an overview of the GWAS of our primary and supplementary phenotypes. "n": GWAS sample size; "Mean ! " ": mean GWAS chi-squared statistics across HapMap3 SNPs with minor allele frequency (MAF) greater than 0.01; "LD Score intercept": estimate of the intercept from a LD Score regression 11 using HapMap3 SNPs with MAF greater than 0.01; "# lead SNPs": number of lead SNPs, calculated after the associated statistics have been adjusted using the estimated LD score intercept; "SNP h 2 ": SNP heritability estimated with the Heritability Estimator from Summary Statistics (HESS) method 38 using 1000 Genomes phase 3
SNPs with MAF greater than 0.05; "disc.": discovery; "rep.": replication; "indep.": independent.
